Page last updated: 2024-08-23

raloxifene hydrochloride and Insulin Resistance

raloxifene hydrochloride has been researched along with Insulin Resistance in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's6 (75.00)29.6817
2010's2 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Anaya-Prado, R; Grover-Páez, F; Zavalza-Gómez, AB1
Lovre, D; Mauvais-Jarvis, F; Xu, B1
Colao, A; Lombardi, G; Mastrantonio, P; Nappi, C; Orio, F; Palomba, S; Russo, T; Sammartino, A; Sbano, FM; Zullo, F1
Botsis, D; Caramalis, G; Christodoulakos, G; Creatsas, G; Lambrinoudaki, I; Panoulis, C; Rizos, D; Sioulas, V1
Ando, H; Kaneko, S; Komura, T; Matsushita, E; Minato, H; Shimizu, A; Takamura, T; Zen, Y1
Gilkison, C; Nagamani, M; Sepilian, V; Szymajda, A; Urban, RJ1
Fajardo, ME; Malacara, JM; Nava, LE1
Anderson, PW; Andersson, B; Bengtsson, BA; Holm, G; Johannsson, G; Mason, T; Pavo, I; Sashegyi, A1

Reviews

1 review(s) available for raloxifene hydrochloride and Insulin Resistance

ArticleYear
The effect of selective estrogen receptor modulators on type 2 diabetes onset in women: Basic and clinical insights.
    Journal of diabetes and its complications, 2017, Volume: 31, Issue:4

    Topics: Aging; Animals; Antineoplastic Agents, Hormonal; Bone Density Conservation Agents; Diabetes Mellitus, Type 2; Energy Metabolism; Female; Humans; Indoles; Insulin Resistance; Models, Biological; Obesity; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Tamoxifen

2017

Trials

5 trial(s) available for raloxifene hydrochloride and Insulin Resistance

ArticleYear
Raloxifene modifies the insulin sensitivity and lipid profile of postmenopausal insulin resistant women.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2013, Volume: 29, Issue:7

    Topics: Adult; Double-Blind Method; Female; Humans; Insulin; Insulin Resistance; Lipid Metabolism; Lipids; Middle Aged; Placebos; Postmenopause; Prediabetic State; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators

2013
Lipid, glucose and homocysteine metabolism in women treated with a GnRH agonist with or without raloxifene.
    Human reproduction (Oxford, England), 2004, Volume: 19, Issue:2

    Topics: Adult; Blood Glucose; Body Constitution; Body Mass Index; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Delayed-Action Preparations; Female; Folic Acid; Homeostasis; Homocysteine; Humans; Insulin; Insulin Resistance; Leiomyoma; Leuprolide; Lipids; Middle Aged; Placebos; Premenopause; Raloxifene Hydrochloride; Triglycerides; Uterine Neoplasms; Vitamin B 12

2004
Effects of raloxifene on insulin sensitivity, beta-cell function, and hepatic insulin extraction in normal postmenopausal women.
    Fertility and sterility, 2008, Volume: 89, Issue:3

    Topics: Blood Glucose; C-Peptide; Fasting; Female; Glycated Hemoglobin; Humans; Insulin; Insulin Resistance; Insulin-Secreting Cells; Lipids; Liver; Middle Aged; Postmenopause; Prospective Studies; Raloxifene Hydrochloride; Reference Values; Selective Estrogen Receptor Modulators; Time Factors

2008
Gonadotropins at menopause: the influence of obesity, insulin resistance, and estrogens.
    Steroids, 2001, Volume: 66, Issue:7

    Topics: Chromans; Clomiphene; Estrogens; Feedback, Physiological; Female; Follicle Stimulating Hormone; Gonadotropins; Humans; Hypoglycemic Agents; Insulin Resistance; Menopause; Metformin; Middle Aged; Obesity; Pregnancy; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Thiazoles; Thiazolidinediones; Troglitazone

2001
Raloxifene does not affect insulin sensitivity or glycemic control in postmenopausal women with type 2 diabetes mellitus: a randomized clinical trial.
    The Journal of clinical endocrinology and metabolism, 2002, Volume: 87, Issue:1

    Topics: Aged; Androgens; Blood Coagulation Factors; Blood Glucose; Cross-Over Studies; Diabetes Mellitus, Type 2; Estrogen Antagonists; Female; Glucose Clamp Technique; Humans; Hyperandrogenism; Insulin Resistance; Insulin-Like Growth Factor I; Lipoproteins; Middle Aged; Postmenopause; Raloxifene Hydrochloride

2002

Other Studies

2 other study(ies) available for raloxifene hydrochloride and Insulin Resistance

ArticleYear
Serum androgen levels and insulin resistance in postmenopausal women: association with hormone therapy, tibolone and raloxifene.
    Maturitas, 2005, Apr-11, Volume: 50, Issue:4

    Topics: Adult; Aged; Androgens; Cross-Sectional Studies; Dehydroepiandrosterone Sulfate; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Insulin; Insulin Resistance; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Postmenopause; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Sex Hormone-Binding Globulin; Testosterone

2005
Selective estrogen receptor modulator raloxifene-associated aggravation of nonalcoholic steatohepatitis.
    Internal medicine (Tokyo, Japan), 2007, Volume: 46, Issue:9

    Topics: Alanine Transaminase; Aspartate Aminotransferases; Chemical and Drug Induced Liver Injury; Fatty Liver; Female; Glucose Intolerance; Humans; Insulin Resistance; Liver; Liver Cirrhosis; Middle Aged; Osteoporosis, Postmenopausal; Raloxifene Hydrochloride; Risk Factors; Selective Estrogen Receptor Modulators; Severity of Illness Index

2007